Literature DB >> 9432722

Animal models of HIV-1 disease.

J M McCune1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9432722     DOI： 10.1126/science.278.5346.2141

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.

Authors:  C A Stoddart; M E Moreno; V D Linquist-Stepps; C Bare; M R Bogan; A Gobbi; R W Buckheit; J Bedard; R F Rando; J M McCune
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice.

Authors:  Kaori Sango; Aviva Joseph; Mahesh Patel; Kristin Osiecki; Monica Dutta; Harris Goldstein
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

Review 3.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

4.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

Authors:  S Fais; C Lapenta; S M Santini; M Spada; S Parlato; M Logozzi; P Rizza; F Belardelli
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Humanized mice for studying human leukocyte integrins in vivo.

Authors:  Sang-Soo Kim; Priti Kumar; Chunting Ye; Premlata Shankar
Journal:  Methods Mol Biol       Date:  2012

Review 7.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.

Authors:  J Kervinen; J Lubkowski; A Zdanov; D Bhatt; B M Dunn; K Y Hui; D J Powell; J Kay; A Wlodawer; A Gustchina
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

Review 9.  Use of humanized severe combined immunodeficient mice for human vaccine development.

Authors:  Gloria C Koo; Aisha Hasan; Richard J O'Reilly
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

10.  CAPIH: a Web interface for comparative analyses and visualization of host-HIV protein-protein interactions.

Authors:  Fan-Kai Lin; Chia-Lin Pan; Jinn-Moon Yang; Trees-Juen Chuang; Feng-Chi Chen
Journal:  BMC Microbiol       Date:  2009-08-12       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.